🇰🇷 ASPARAGINASE ERWINIA CHRYSANTHEMI in South Korea

ASPARAGINASE ERWINIA CHRYSANTHEMI (ASPARAGINASE ERWINIA CHRYSANTHEMI) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

ASPARAGINASE ERWINIA CHRYSANTHEMI in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is ASPARAGINASE ERWINIA CHRYSANTHEMI approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for ASPARAGINASE ERWINIA CHRYSANTHEMI in South Korea?

Marketing authorisation holder not available in our data.